share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph

SEC announcement ·  Jun 19 04:21
Summary by Futu AI
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase of common stock on June 17, 2024. The transaction involved the acquisition of 13 shares at a price of $885.01 per share. Following this transaction, Alvarez directly holds a total of 54,138 shares in the company. The transaction, which is classified as a grant, award, or other acquisition, reflects a continued investment in the company by Alvarez and is indicative of his direct ownership stake in Eli Lilly.
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase of common stock on June 17, 2024. The transaction involved the acquisition of 13 shares at a price of $885.01 per share. Following this transaction, Alvarez directly holds a total of 54,138 shares in the company. The transaction, which is classified as a grant, award, or other acquisition, reflects a continued investment in the company by Alvarez and is indicative of his direct ownership stake in Eli Lilly.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.